MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/20420986261467891

Медицинская библиотека · Therapeutic advances in drug safety · 2026

Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data.

Tran Ngan Thi, Pham Tung My, Ngo Mai Thi Quynh, Tran Anh Van, Ninh Thu Thi Kim, Nguyen Long Duc, Hoang Dung Van, Nguyen Phuong Thi Thu

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Drug-induced liver injury (DILI) is difficult to diagnose and manage in routine care because it lacks pathognomonic biomarkers and is often recognized only after clinically meaningful injury has occurred. Existing computational approaches are largely drug-centric and do not routinely incorporate patient-level clinical data available in electronic health records (EHRs).

OBJECTIVES

To develop and temporally validate a machine learning model for episode-level risk stratification of Roussel Uclaf Causality Assessment Method (RUCAM)-defined DILI using routinely available baseline clinical data.

DESIGN

This was an observational cohort study conducted at Hai Phong International Hospital using linked EHR, laboratory, and pharmacy data. The final labeled cohort was partitioned chronologically at the patient level into a retrospective development cohort (2019-2023) and a temporally subsequent prospective validation cohort (2024-2025).

METHODS

Eligible drug-exposure episodes with complete baseline liver biochemistry and key exposure covariates were included. Analysis-ready episodes were monitored for biochemical liver injury triggers, and trigger-positive episodes underwent clinical review and RUCAM adjudication. DILI was defined as RUCAM ⩾6. Predictors were limited to baseline demographics, comorbidities, laboratory values, drug-exposure features, and FDA DILIrank 2.0 metadata. Candidate models included logistic regression, elastic-net logistic regression, random forest, ExtraTrees, XGBoost, and LightGBM.

RESULTS

Among 5095 eligible episodes from 3579 patients, 2786 episodes from 2712 patients were analysis-ready after exclusions. The final labeled cohort comprised 274 DILI-positive and 2512 non-DILI episodes. The prospective validation cohort included 828 episodes, of which 108 (13.0%) were DILI-positive. Tree-based ensemble models outperformed regression-based models. Logistic regression achieved an area under the receiver operating characteristic curve (AUROC) of 0.777 and an area under the precision-recall curve (PR-AUC) of 0.349, whereas the final LightGBM model achieved an AUROC of 0.965 (95% CI 0.942-0.983), a PR-AUC of 0.903 (95% CI 0.856-0.943), and a Brier score of 0.034.

CONCLUSION

A prospectively validated machine learning model using routinely collected baseline clinical data showed excellent performance for DILI risk stratification and may strengthen hospital pharmacovigilance.

Для цитирования: Tran Ngan Thi, Pham Tung My, Ngo Mai Thi Quynh, Tran Anh Van, Ninh Thu Thi Kim, Nguyen Long Duc, Hoang Dung Van, Nguyen Phuong Thi Thu. Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data.. Therapeutic advances in drug safety. 2026. DOI: 10.1177/20420986261467891.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.